APO Research

APO RESEARCH · REPORT

Isoniazid

Selected research

Market Outlook & Growth Opportunities

Global Isoniazid Market Outlook and Growth Opportunities 2026

Market perspective

The global Isoniazid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Isoniazid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Isoniazid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isoniazid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Isoniazid market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Isoniazid market include AMSAL CHEM, Zhejiang Second Pharma, Taizhou Tianrui Pharmaceutical, Titan Pharma (India), Resonance Specialties, Camus pharma and Calyx Pharma & Chem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Isoniazid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Isoniazid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Isoniazid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isoniazid market size, projected growth trends, production technologies, key applications, and end-use industries.

Isoniazid Segment by Company

AMSAL CHEM

Zhejiang Second Pharma

Taizhou Tianrui Pharmaceutical

Titan Pharma (India)

Resonance Specialties

Camus pharma

Calyx Pharma & Chem

Isoniazid Segment by Type

Above 98% Isoniazid

Below 98% Isoniazid

Isoniazid Segment by Application

Hospital

Clinic

Others

Isoniazid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Isoniazid status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Isoniazid market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Isoniazid significant trends, drivers, influence factors in global and regions.

6. To analyze Isoniazid competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoniazid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isoniazid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoniazid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Isoniazid market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isoniazid industry.

Chapter 3: Detailed analysis of Isoniazid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Isoniazid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Isoniazid in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Isoniazid Industry Trends Table 2. Isoniazid Industry Drivers Table 3. Isoniazid Industry Opportunities and Challenges Table 4. Isoniazid Industry Restraints Table 5. Global Isoniazid Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Isoniazid Revenue Share by Company (2021-2026) Table 7. Global Isoniazid Sales Volume by Company (W Tons) & (2021-2026) Table 8. Global Isoniazid Sales Volume Share by Company (2021-2026) Table 9. Global Isoniazid Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Isoniazid Company Ranking, (2024-2026) & (USD Million) Table 11. Global Isoniazid Key Company Manufacturing Base & Headquarters Table 12. Global Isoniazid Company, Product Type & Application Table 13. Global Isoniazid Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Isoniazid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Above 98% Isoniazid Table 18. Significant Companies of Below 98% Isoniazid Table 19. Global Isoniazid Sales Volume by Type 2021 VS 2025 VS 2032 (W Tons) Table 20. Global Isoniazid Sales Volume by Type (2021-2026) & (W Tons) Table 21. Global Isoniazid Sales Volume by Type (2027-2032) & (W Tons) Table 22. Global Isoniazid Sales Volume Share by Type (2021-2026) Table 23. Global Isoniazid Sales Volume Share by Type (2027-2032) Table 24. Global Isoniazid Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Isoniazid Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Isoniazid Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Isoniazid Sales Value Share by Type (2021-2026) Table 28. Global Isoniazid Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Isoniazid Sales Volume by Application 2021 VS 2025 VS 2032 (W Tons) Table 33. Global Isoniazid Sales Volume by Application (2021-2026) & (W Tons) Table 34. Global Isoniazid Sales Volume by Application (2027-2032) & (W Tons) Table 35. Global Isoniazid Sales Volume Share by Application (2021-2026) Table 36. Global Isoniazid Sales Volume Share by Application (2027-2032) Table 37. Global Isoniazid Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Isoniazid Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Isoniazid Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Isoniazid Sales Value Share by Application (2021-2026) Table 41. Global Isoniazid Sales Value Share by Application (2027-2032) Table 42. Global Isoniazid Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 43. Global Isoniazid Sales by Region (2021-2026) & (W Tons) Table 44. Global Isoniazid Sales Market Share by Region (2021-2026) Table 45. Global Isoniazid Sales by Region (2027-2032) & (W Tons) Table 46. Global Isoniazid Sales Market Share by Region (2027-2032) Table 47. Global Isoniazid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Isoniazid Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Isoniazid Sales Value Share by Region (2021-2026) Table 50. Global Isoniazid Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Isoniazid Sales Value Share by Region (2027-2032) Table 52. Global Isoniazid Market Average Price (US$/Ton) by Region (2021-2026) Table 53. Global Isoniazid Market Average Price (US$/Ton) by Region (2027-2032) Table 54. Global Isoniazid Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Table 55. Global Isoniazid Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Isoniazid Sales by Country (2021-2026) & (W Tons) Table 57. Global Isoniazid Sales Market Share by Country (2021-2026) Table 58. Global Isoniazid Sales by Country (2027-2032) & (W Tons) Table 59. Global Isoniazid Sales Market Share by Country (2027-2032) Table 60. Global Isoniazid Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Isoniazid Sales Value Market Share by Country (2021-2026) Table 62. Global Isoniazid Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Isoniazid Sales Value Market Share by Country (2027-2032) Table 64. AMSAL CHEM Company Information Table 65. AMSAL CHEM Business Overview Table 66. AMSAL CHEM Isoniazid Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. AMSAL CHEM Isoniazid Product Portfolio Table 68. AMSAL CHEM Recent Development Table 69. Zhejiang Second Pharma Company Information Table 70. Zhejiang Second Pharma Business Overview Table 71. Zhejiang Second Pharma Isoniazid Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Zhejiang Second Pharma Isoniazid Product Portfolio Table 73. Zhejiang Second Pharma Recent Development Table 74. Taizhou Tianrui Pharmaceutical Company Information Table 75. Taizhou Tianrui Pharmaceutical Business Overview Table 76. Taizhou Tianrui Pharmaceutical Isoniazid Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Taizhou Tianrui Pharmaceutical Isoniazid Product Portfolio Table 78. Taizhou Tianrui Pharmaceutical Recent Development Table 79. Titan Pharma (India) Company Information Table 80. Titan Pharma (India) Business Overview Table 81. Titan Pharma (India) Isoniazid Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Titan Pharma (India) Isoniazid Product Portfolio Table 83. Titan Pharma (India) Recent Development Table 84. Resonance Specialties Company Information Table 85. Resonance Specialties Business Overview Table 86. Resonance Specialties Isoniazid Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Resonance Specialties Isoniazid Product Portfolio Table 88. Resonance Specialties Recent Development Table 89. Camus pharma Company Information Table 90. Camus pharma Business Overview Table 91. Camus pharma Isoniazid Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Camus pharma Isoniazid Product Portfolio Table 93. Camus pharma Recent Development Table 94. Calyx Pharma & Chem Company Information Table 95. Calyx Pharma & Chem Business Overview Table 96. Calyx Pharma & Chem Isoniazid Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Calyx Pharma & Chem Isoniazid Product Portfolio Table 98. Calyx Pharma & Chem Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Isoniazid Distributors List Table 102. Isoniazid Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Isoniazid Product Image Figure 2. Global Isoniazid Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isoniazid Sales Value (2021-2032) & (US$ Million) Figure 4. Global Isoniazid Sales (2021-2032) & (W Tons) Figure 5. Global Isoniazid Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Isoniazid Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Above 98% Isoniazid Image Figure 10. Below 98% Isoniazid Image Figure 11. Global Isoniazid Sales Volume by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 12. Global Isoniazid Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Isoniazid Sales Volume Share by Type (2021-2032) Figure 14. Global Isoniazid Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Isoniazid Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Isoniazid Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Isoniazid Sales Volume by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 21. Global Isoniazid Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Isoniazid Sales Volume Share by Application (2021-2032) Figure 23. Global Isoniazid Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Isoniazid Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Isoniazid Sales Value Share by Application (2021-2032) Figure 26. Global Isoniazid Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 27. Global Isoniazid Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Isoniazid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Isoniazid Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Isoniazid Sales Value (2021-2032) & (US$ Million) Figure 31. North America Isoniazid Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Isoniazid Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Isoniazid Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Isoniazid Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Isoniazid Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Isoniazid Sales Value (2021-2032) & (US$ Million) Figure 37. South America Isoniazid Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Isoniazid Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Isoniazid Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Isoniazid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Isoniazid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Isoniazid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Isoniazid Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Isoniazid Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Above 98% Isoniazid
  • Below 98% Isoniazid
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • AMSAL CHEM
  • Zhejiang Second Pharma
  • Taizhou Tianrui Pharmaceutical
  • Titan Pharma (India)
  • Resonance Specialties
  • Camus pharma
  • Calyx Pharma & Chem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Isoniazid Sales Value (2021-2032)
  4. 1.2.2 Global Isoniazid Sales Volume (2021-2032)
  5. 1.2.3 Global Isoniazid Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Isoniazid Market Dynamics
  1. 2.1 Isoniazid Industry Trends
  2. 2.2 Isoniazid Industry Drivers
  3. 2.3 Isoniazid Industry Opportunities and Challenges
  4. 2.4 Isoniazid Industry Restraints
3 Isoniazid Market by Company
  1. 3.1 Global Isoniazid Company Revenue Ranking in 2025
  2. 3.2 Global Isoniazid Revenue by Company (2021-2026)
  3. 3.3 Global Isoniazid Sales Volume by Company (2021-2026)
  4. 3.4 Global Isoniazid Average Price by Company (2021-2026)
  5. 3.5 Global Isoniazid Company Ranking (2024-2026)
  6. 3.6 Global Isoniazid Company Manufacturing Base and Headquarters
  7. 3.7 Global Isoniazid Company Product Type and Application
  8. 3.8 Global Isoniazid Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Isoniazid Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Isoniazid Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Isoniazid Market by Type
  1. 4.1 Isoniazid Type Introduction
  2. 4.1.1 Above 98% Isoniazid
  3. 4.1.2 Below 98% Isoniazid
  4. 4.2 Global Isoniazid Sales Volume by Type
  5. 4.2.1 Global Isoniazid Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Isoniazid Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Isoniazid Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Isoniazid Sales Value by Type
  9. 4.3.1 Global Isoniazid Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Isoniazid Sales Value by Type (2021-2032)
  11. 4.3.3 Global Isoniazid Sales Value Share by Type (2021-2032)
5 Isoniazid Market by Application
  1. 5.1 Isoniazid Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Isoniazid Sales Volume by Application
  6. 5.2.1 Global Isoniazid Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Isoniazid Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Isoniazid Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Isoniazid Sales Value by Application
  10. 5.3.1 Global Isoniazid Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Isoniazid Sales Value by Application (2021-2032)
  12. 5.3.3 Global Isoniazid Sales Value Share by Application (2021-2032)
6 Isoniazid Regional Sales and Value Analysis
  1. 6.1 Global Isoniazid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Isoniazid Sales by Region (2021-2032)
  3. 6.2.1 Global Isoniazid Sales by Region: 2021-2026
  4. 6.2.2 Global Isoniazid Sales by Region (2027-2032)
  5. 6.3 Global Isoniazid Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Isoniazid Sales Value by Region (2021-2032)
  7. 6.4.1 Global Isoniazid Sales Value by Region: 2021-2026
  8. 6.4.2 Global Isoniazid Sales Value by Region (2027-2032)
  9. 6.5 Global Isoniazid Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Isoniazid Sales Value (2021-2032)
  12. 6.6.2 North America Isoniazid Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Isoniazid Sales Value (2021-2032)
  15. 6.7.2 Europe Isoniazid Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Isoniazid Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Isoniazid Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Isoniazid Sales Value (2021-2032)
  21. 6.9.2 South America Isoniazid Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Isoniazid Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Isoniazid Sales Value Share by Country, 2025 VS 2032
7 Isoniazid Country-level Sales and Value Analysis
  1. 7.1 Global Isoniazid Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Isoniazid Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Isoniazid Sales by Country (2021-2032)
  4. 7.3.1 Global Isoniazid Sales by Country (2021-2026)
  5. 7.3.2 Global Isoniazid Sales by Country (2027-2032)
  6. 7.4 Global Isoniazid Sales Value by Country (2021-2032)
  7. 7.4.1 Global Isoniazid Sales Value by Country (2021-2026)
  8. 7.4.2 Global Isoniazid Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Isoniazid Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Isoniazid Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Isoniazid Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Isoniazid Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Isoniazid Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Isoniazid Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Isoniazid Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Isoniazid Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Isoniazid Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Isoniazid Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Isoniazid Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Isoniazid Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Isoniazid Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Isoniazid Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Isoniazid Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Isoniazid Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Isoniazid Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Isoniazid Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Isoniazid Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Isoniazid Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Isoniazid Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Isoniazid Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Isoniazid Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Isoniazid Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Isoniazid Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Isoniazid Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Isoniazid Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Isoniazid Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Isoniazid Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Isoniazid Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Isoniazid Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Isoniazid Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Isoniazid Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Isoniazid Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Isoniazid Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Isoniazid Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Isoniazid Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Isoniazid Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Isoniazid Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Isoniazid Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Isoniazid Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Isoniazid Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Isoniazid Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Isoniazid Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Isoniazid Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Isoniazid Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Isoniazid Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Isoniazid Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Isoniazid Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Isoniazid Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Isoniazid Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Isoniazid Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Isoniazid Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Isoniazid Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Isoniazid Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Isoniazid Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Isoniazid Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Isoniazid Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Isoniazid Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Isoniazid Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Isoniazid Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Isoniazid Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Isoniazid Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Isoniazid Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Isoniazid Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Isoniazid Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Isoniazid Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Isoniazid Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Isoniazid Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Isoniazid Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Isoniazid Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Isoniazid Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Isoniazid Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Isoniazid Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Isoniazid Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Isoniazid Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Isoniazid Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Isoniazid Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Isoniazid Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Isoniazid Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Isoniazid Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Isoniazid Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Isoniazid Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Isoniazid Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AMSAL CHEM
  2. 8.1.1 AMSAL CHEM Company Information
  3. 8.1.2 AMSAL CHEM Business Overview
  4. 8.1.3 AMSAL CHEM Isoniazid Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AMSAL CHEM Isoniazid Product Portfolio
  6. 8.1.5 AMSAL CHEM Recent Developments
  7. 8.2 Zhejiang Second Pharma
  8. 8.2.1 Zhejiang Second Pharma Company Information
  9. 8.2.2 Zhejiang Second Pharma Business Overview
  10. 8.2.3 Zhejiang Second Pharma Isoniazid Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Second Pharma Isoniazid Product Portfolio
  12. 8.2.5 Zhejiang Second Pharma Recent Developments
  13. 8.3 Taizhou Tianrui Pharmaceutical
  14. 8.3.1 Taizhou Tianrui Pharmaceutical Company Information
  15. 8.3.2 Taizhou Tianrui Pharmaceutical Business Overview
  16. 8.3.3 Taizhou Tianrui Pharmaceutical Isoniazid Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Taizhou Tianrui Pharmaceutical Isoniazid Product Portfolio
  18. 8.3.5 Taizhou Tianrui Pharmaceutical Recent Developments
  19. 8.4 Titan Pharma (India)
  20. 8.4.1 Titan Pharma (India) Company Information
  21. 8.4.2 Titan Pharma (India) Business Overview
  22. 8.4.3 Titan Pharma (India) Isoniazid Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Titan Pharma (India) Isoniazid Product Portfolio
  24. 8.4.5 Titan Pharma (India) Recent Developments
  25. 8.5 Resonance Specialties
  26. 8.5.1 Resonance Specialties Company Information
  27. 8.5.2 Resonance Specialties Business Overview
  28. 8.5.3 Resonance Specialties Isoniazid Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Resonance Specialties Isoniazid Product Portfolio
  30. 8.5.5 Resonance Specialties Recent Developments
  31. 8.6 Camus pharma
  32. 8.6.1 Camus pharma Company Information
  33. 8.6.2 Camus pharma Business Overview
  34. 8.6.3 Camus pharma Isoniazid Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Camus pharma Isoniazid Product Portfolio
  36. 8.6.5 Camus pharma Recent Developments
  37. 8.7 Calyx Pharma & Chem
  38. 8.7.1 Calyx Pharma & Chem Company Information
  39. 8.7.2 Calyx Pharma & Chem Business Overview
  40. 8.7.3 Calyx Pharma & Chem Isoniazid Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Calyx Pharma & Chem Isoniazid Product Portfolio
  42. 8.7.5 Calyx Pharma & Chem Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Isoniazid Value Chain Analysis
  2. 9.1.1 Isoniazid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Isoniazid Sales Mode & Process
  6. 9.2 Isoniazid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Isoniazid Distributors
  9. 9.2.3 Isoniazid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research